ukwelashwa kwe-metastatic non small cell lung cancer treatment

Ukwelashwa Kwe-Metastatic Non-Small Cell Cancer Lesi sihloko sinikeza ukubuka okuphelele kwezinketho zokwelapha umdlavuza wamaphaphu we-metastatic ongewona omncane (i-NSCLC), okuhlanganisa ukwelashwa ngamakhemikhali, ukwelapha okuhlosiwe, i-immunotherapy, kanye nokwelashwa ngemisebe. Sihlola intuthuko yakamuva kanye nokucatshangelwa kokukhetha uhlelo lokwelapha olusebenza kahle kakhulu olusekelwe ezintweni zesiguli ngasinye. Lolu lwazi ngelezinjongo zokufundisa kuphela futhi akufanele luthathwe njengeseluleko sezokwelapha. Hlala uthintana nomhlinzeki wakho wokunakekelwa kwezempilo ukuze uthole ukuqondiswa komuntu siqu.

Ukuqonda I-Metastatic Non-Small Cell Lung Cancer

I-Metastatic non-small cell lung cancer (NSCLC) kwenzeka lapho amangqamuzana omdlavuza asuka emaphashini esakazekela kwezinye izingxenye zomzimba. Lesi yisimo esibucayi esidinga indlela ehlukahlukene yokwelashwa. Isu elithile lokwelapha lincike ezicini eziningana, okuhlanganisa uhlobo nesigaba somdlavuza, impilo yesiguli iyonke, kanye nendawo yama-metastase. Ukuxilongwa kusenesikhathi kanye nokwelashwa okufanele kubalulekile ukuze kuthuthukiswe imiphumela.

Izinketho Zokwelashwa ze-Metastatic NSCLC

I-Chemotherapy

I-Chemotherapy iyindlela yokwelapha evamile umdlavuza wamaphaphu we-metastatic ongewona omncane, ukusebenzisa izidakamizwa ukubulala amangqamuzana omdlavuza. Izinhlobo ezahlukene zemithi yokwelapha ngamakhemikhali zikhona, futhi ukukhetha kuncike ezicini ezihlukahlukene, njengempilo evamile yesiguli kanye nohlobo oluthile lwe-NSCLC. Izidakamizwa ezivamile ze-chemotherapy ezisetshenziswayo zihlanganisa i-cisplatin, i-carboplatin, i-paclitaxel, ne-docetaxel. Imiphumela engemihle ingahluka kodwa ngokuvamile ihlanganisa isicanucanu, ukukhathala, nokulahlekelwa izinwele. I I-National Cancer Institute inikeza ulwazi oluningiliziwe ngemithi ye-chemotherapy ye-NSCLC.

Ukwelapha Okuhlosiwe

Ukwelapha okuhlosiwe kusebenzisa izidakamizwa eziqondise ngokuqondile amangqamuzana omdlavuza anezinguquko ezithile zofuzo. Lezi zindlela zokwelapha zisebenza kakhulu ezigulini ezine-NSCLC ephethe izinguquko ezithile zofuzo, njenge-EGFR, ALK, ROS1, noma ukuguqulwa kwe-BRAF. Izibonelo zemithi yokwelapha ehlosiwe zifaka i-osimertinib (Tagrisso), i-crizotinib (Xalkori), ne-afatinib (Gilotrif). Nakuba kuphumelela, ukwelapha okuhlosiwe kungaholela emiphumeleni engemihle, njengokuqubuka kwesikhumba, isifo sohudo, nezinkinga zesibindi. Ukuhlolwa kwezakhi zofuzo kubalulekile ukuze kutholakale iziguli okungenzeka zizuze ekwelashweni okuqondiwe.

I-Immunotherapy

I-Immunotherapy ihlanganisa amasosha omzimba ukuze alwe namaseli omdlavuza. Lezi zindlela zokwelapha zibaluleke kakhulu ekwelapheni umdlavuza wamaphaphu we-metastatic ongewona omncane. Ama-immune checkpoint inhibitors, njenge-pembrolizumab (Keytruda) kanye ne-nivolumab (Opdivo), avimba amaprotheni avimbela amasosha omzimba ekuhlaseleni amangqamuzana omdlavuza. Ngenkathi inikeza izimpendulo eziphawulekayo kwezinye iziguli, i-immunotherapy ingaba nemiphumela engemihle, kuhlanganise nokukhathala, ukuqubuka, nokuvuvukala. Ukufaneleka kwe-immunotherapy kuncike ezintweni ezifana ne-PD-L1 expression kanye nomthwalo we-tumor mutational.

Ukwelapha Ngemisebe

Ukwelashwa ngemisebe kusebenzisa imisebe enamandla amakhulu ukubulala amangqamuzana omdlavuza. Ingasetshenziselwa ukwelapha ama-metastases asendaweni noma ukunciphisa izimpawu ezibangelwa umdlavuza, njengobuhlungu noma ubunzima bokuphefumula. Izinhlobo ezahlukene zokwelapha ngemisebe zikhona, okuhlanganisa imisebe yangaphandle ye-beam kanye ne-brachytherapy. Imiphumela engemihle yokwelashwa ngemisebe ingase ihlanganise ukucasuka kwesikhumba, ukukhathala, nesicanucanu.

Ukukhetha Ukwelashwa kanye Nezici Zesiguli

Ukukhetha uhlelo lokwelapha olufanele umdlavuza wamaphaphu we-metastatic ongewona omncane kudinga ukuhlolwa okuphelele kwezici ezimbalwa. Lokhu kuhlanganisa impilo yesiguli iyonke, isimo sokusebenza, isigaba nezici zomdlavuza, kanye nokuba khona kwanoma yiziphi izinguquko zofuzo ezithile. Ithimba lezinhlaka eziningi lodokotela be-oncologists, ama-radiologists, odokotela abahlinzayo, nabanye ochwepheshe bezempilo ngokuvamile bayasebenzisana ukuze benze uhlelo lokwelapha lomuntu siqu.

I-Shandong Baofa Cancer Research Institute (https://www.baofahospital.com/) inikezelwe ekuhlinzekeni ukunakekelwa okuthuthukisiwe komdlavuza kanye nocwaningo, kusetshenziswa ubuchwepheshe obusezingeni eliphezulu kanye nendlela yokuhlanganyela yokuletha imiphumela yesiguli eyingqayizivele. Bahlinzeka ngezinsizakalo zokuxilonga nezokwelashwa ezibanzi zezinhlobo ezahlukene zomdlavuza, okuhlanganisa umdlavuza wamaphaphu we-metastatic ongewona omncane.

Ucwaningo Oluqhubekayo Neziqondiso Zesikhathi esizayo

Ucwaningo luyaqhubeka nokuqhubekisela phambili ukuqonda kanye nokwelashwa kwe umdlavuza wamaphaphu we-metastatic ongewona omncane. Izindlela zokwelapha ezihlosiwe ezintsha, ama-immunotherapies, nezinhlanganisela zakho zihlala zithuthukiswa futhi zihlolwa ezivivinyweni zomtholampilo. Lokhu kuthuthuka kunikeza ithemba lemiphumela yokwelashwa ethuthukisiwe kanye nekhwalithi yempilo ethuthukisiwe yeziguli.

Umshwana wokuzihlangula: Lolu lwazi lwenzelwe izinjongo zokufundisa kuphela futhi akufanele luthathwe njengeseluleko sezokwelapha. Hlala uthintana nomhlinzeki wakho wokunakekelwa kwezempilo ukuze uthole ukuqondiswa komuntu siqu mayelana nesimo sakho esithile.